Stem cell derived exosome preparation for preventing and treating lung jury

An exosome and stem cell technology, applied in the field of stem cell therapy and regenerative medicine, can solve the problem of lack of a good treatment method, and achieve the effect of promoting recovery and enhancing the therapeutic effect.

Inactive Publication Date: 2018-12-25
NANKAI UNIV
View PDF3 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there is no good clinical treatment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Stem cell derived exosome preparation for preventing and treating lung jury
  • Stem cell derived exosome preparation for preventing and treating lung jury
  • Stem cell derived exosome preparation for preventing and treating lung jury

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] Example 1, the present invention provides a method for preparing an exosome preparation derived from stem cells.

[0016] Reagents such as cell culture medium, penicillin / streptomycin, trypsin, sodium pyruvate, and glutamine were all purchased from Gibco Company; culture flasks and well plates required for cell culture were purchased from Corning Company. The serum used for cell culture was Hyclone, and the serum concentration was 10%.

[0017] Refer to "Animal Cell Culture (Sixth Edition)" for common cytological procedures such as cell recovery, culture, subculture, and cryopreservation.

[0018] Preparation of exosome-free serum: Fetal bovine serum was centrifuged at 120,000 g at 4°C for 2 h, the supernatant was extracted (exosomes were precipitated), filtered and sterilized with a 0.22 μm filter, and prepared to a final concentration of 10% for culture Base spare.

[0019] Collection of exosome conditioned medium: Stem cell culture, when the growth reaches 80%, rem...

Embodiment 2

[0028] Example 2, the present invention provides a method for identifying stem cell-derived exosome preparations.

[0029] Size analysis of exosomes: Dilute the exosomes adjusted to the above concentration 400 times with pure water, and then use the nanoparticle tracking analyzer to analyze and image the suspended exosomes one by one. The analysis results are as follows: figure 1 a. The particle size of exosomes derived from stem cells is 0-200nm, with an average particle size of 120nm.

[0030] Analysis of exosome surface protein expression: detection of exosome surface protein markers by Western blot, the experimental steps are as follows:

[0031] (1) Protein sample preparation: Add 5× loading buffer (Kangwei reagent) to the above quantified exosomes, bathe in boiling water for 10 minutes, and store at -80°C.

[0032] (2) Preparation of polyacrylamide electrophoresis separation gel

[0033] Clean the long and short glass plates and the combs required for film preparation...

Embodiment 3

[0052] Example 3, the present invention provides methods for constructing mouse models of acute lung injury, radiation lung injury, pulmonary fibrosis, and silicosis.

[0053] Establishment of acute lung injury in mice: weigh the mice, anesthetize the mice with intraperitoneal injection of 4% chloral hydrate (330 mg / kg); fix the anesthetized mice in supine position, and fix the limbs and head teeth; cold light source lamp Irradiate from between the chest and neck; pull out the tongue with tweezers to expose the oral cavity; wipe off the saliva in the oral cavity with a cotton swab, and adjust the position of the light source to see the opening and closing movement of the pharynx, and the bright dot in the middle is the entrance of the trachea; Cannulation was performed with a 22G cannula; after intubation, 10 8 CFU E. coli (dissolved in 100 μL PBS). The untreated group was used as the normal control group, and the animals were randomly divided into two groups after surgery: t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a stem cell derived exosome preparation for preventing and treating lung jury. Lung injury includes acute lung injury, radiation lung injury, pulmonary fibrosis, silicosis and the like. The preparation is prepared from stem cell derived exosomes, and after a trachea cannula or intravenous injection reaches injured lungs, recovery of injured tissue structure and function is promoted; the preparation is an acellular preparation, so that the risk of cell mutation is lowered; the stem cell derived exosomes repair and maintain the function in lung tissue; treatment effect oflung injury and fibrosis is enhanced.

Description

technical field [0001] The invention relates to using exosome preparation derived from stem cells to enhance its therapeutic effect in lung tissue injury, and belongs to the technical field of stem cell therapy and regenerative medicine. Background technique [0002] Stem cells are a kind of pluripotent cells with multi-lineage differentiation ability. Human heavy stem cells are derived from a type of heterogeneous pluripotent stem cells in the early developmental mesoderm, and are distributed in various tissues such as bone marrow, fat, umbilical cord, and placenta. Human mesenchymal stem cells highly expressed CD105, CD90, CD73, and CD44, and lowly expressed CD45, CD34, CD14, CD79α and human leukocyte antigen. Human-derived mesenchymal stem cells can be differentiated into various cells in vitro, such as osteoblasts, chondrocytes, adipocytes, etc. Mesenchymal stem cells have low expression of major histocompatibility complex, Fas ligand, co-stimulatory molecules, etc., a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K35/28A61K35/22A61K35/44A61K35/34A61P11/00
CPCA61K9/0019A61K35/22A61K35/28A61K35/34A61K35/44A61P11/00
Inventor 李宗金雷旭丹
Owner NANKAI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap